Immediate Impact
1 from Science/Nature 79 standout
Citing Papers
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
2022 Standout
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
Works of Maureen Heldmann being referenced
Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maureen Heldmann | 158 | 145 | 80 | 26 | 344 | |
| Şeyma Yıldız | 99 | 128 | 87 | 37 | 411 | |
| Elizabeth Yung | 136 | 105 | 73 | 22 | 391 | |
| Francesco Agnello | 114 | 130 | 49 | 25 | 381 | |
| Anjum Khan | 97 | 107 | 176 | 20 | 377 | |
| Rakesh Kumar | 190 | 81 | 77 | 29 | 348 | |
| S. Tzila Zwas | 111 | 92 | 68 | 28 | 387 | |
| Imene Zerizer | 98 | 130 | 29 | 23 | 367 | |
| Ανδρέας Κουρέας | 117 | 51 | 84 | 31 | 372 | |
| Eun Ji Han | 127 | 150 | 49 | 45 | 408 | |
| Gavin C. Mackie | 161 | 84 | 36 | 25 | 310 |
All Works
Loading papers...